Mstarin is a prescription medication containing midostaurin, a kinase inhibitor used to treat certain types of leukemia.
Composition: Mstarin contains 25mg of midostaurin, a protein kinase inhibitor.
Mechanism of Action: Midostaurin works by inhibiting the activity of certain enzymes in the body, which helps to prevent the growth and spread of cancer cells. Specifically, it inhibits the activity of protein kinases, which are enzymes that help to regulate cell growth and survival.
Uses: Mstarin is used to treat:
- Acute myeloid leukemia (AML) with FLT3 mutations
- Systemic mastocytosis (SM) with associated hematological neoplasm
Dosage: The recommended dosage of Mstarin is:
- 25mg taken orally twice daily, with or without food.
Side Effects: Common side effects of Mstarin may include:
- Nausea
- Vomiting
- Fatigue
- Headache
- Diarrhea
- Abdominal pain
- Increased liver enzymes
- Changes in blood cell counts
- Joint pain
- Muscle weakness
Recommendation: Mstarin is recommended for patients who have been diagnosed with AML or SM and have a FLT3 mutation. It is important to discuss the potential benefits and risks of Mstarin with your doctor before starting treatment.
Important Note:
- Mstarin is a prescription medication and should only be used under the guidance of a healthcare provider.
- Patients taking Mstarin should avoid taking any other medications that may interact with midostaurin, such as warfarin, anticoagulants, and certain antibiotics.
- Patients taking Mstarin should report any changes in their blood cell counts, including low white blood cell counts, to their doctor.
- Patients taking Mstarin should not donate blood or sperm during treatment and for at least 2 weeks after stopping treatment.
- Patients taking Mstarin should not breastfeed during treatment and for at least 2 weeks after stopping treatment.
Reviews
There are no reviews yet.